Nordicus Partners Corp Files 8-K

Ticker: NORD · Form: 8-K · Filed: Mar 6, 2025 · CIK: 1011060

Sentiment: neutral

Topics: 8-K, corporate-filing, regulation-fd

TL;DR

Nordicus Partners Corp filed an 8-K on 3/6/25. Standard corporate update.

AI Summary

Nordicus Partners Corp. filed an 8-K on March 6, 2025, reporting information under Regulation FD Disclosure and Financial Statements and Exhibits. The company, formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC, is incorporated in Delaware and its fiscal year ends on March 31.

Why It Matters

This filing indicates routine corporate reporting, including financial updates and regulatory disclosures, which are important for investors to monitor the company's status.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for corporate reporting and does not indicate any immediate financial distress or significant operational changes.

Key Numbers

Key Players & Entities

FAQ

What specific items are being disclosed in this 8-K filing?

This 8-K filing includes disclosures under Regulation FD and pertains to Financial Statements and Exhibits.

When was Nordicus Partners Corp incorporated?

Nordicus Partners Corp was incorporated in Delaware.

What is the fiscal year end for Nordicus Partners Corp?

The fiscal year end for Nordicus Partners Corp is March 31.

What were some of the previous names of Nordicus Partners Corp?

Nordicus Partners Corp was formerly known as EKIMAS Corp, AdvanSource Biomaterials Corp, and CARDIOTECH INTERNATIONAL INC.

What is the business address of Nordicus Partners Corp?

The business address of Nordicus Partners Corp is 280 South Beverly Dr., Suite 505, Beverly Hills, CA 90212.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on March 6, 2025 regarding Nordicus Partners Corp (NORD).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing